Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 3/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 3/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27540720 | 0.86 | EDNRA (0.37) | EDNRAESR1ESR2ALDH1A1LMNA | |
| SCHEMBL21946447 | 0.79 | OPRD1 (0.37) | EDNRAESR1ESR2ALDH1A1LMNA | |
| SCHEMBL28258278 | 0.79 | BRD4 (0.48) | EDNRAALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL13991613 | 0.77 | AHR (0.40) | ESR1ESR2ALDH1A1KMT2AMEN1 | |
| SCHEMBL10068090 | 0.77 | BRD4 (0.46) | ESR1ESR2ALDH1A1LMNAMAPT | |
| SCHEMBL18165282 | 0.75 | ALDH1A1 (0.36) | EDNRAALDH1A1LMNAMAPTKDM4E | |
| SCHEMBL13287870 | 0.75 | MAOB (0.38) | EDNRAESR1ESR2LMNAMAPT | |
| SCHEMBL27950503 | 0.75 | EDNRA (0.52) | EDNRAALDH1A1KMT2APTGS2BRD4 | |
| SCHEMBL1257771 | 0.74 | MAOA (0.41) | EDNRAESR1ESR2ALDH1A1LMNA | |
| SCHEMBL2009426 | 0.74 | ESR1 (0.36) | ESR1ESR2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9832880-B2 | Electronic apparatus and method for manufacturing the same | Innolux Corporation (TW) | 2017-11-28 | — | — | US | disclosed |
| US-9832880-B2 | Electronic apparatus and method for manufacturing the same | Innolux Corporation (TW) | 2017-11-28 | — | — | US | disclosed |
| US-20140362545-A1 | ELECTRONIC APPARATUS AND METHOD FOR MANUFACTURING THE SAME | Innolux Corporation (TW) | 2014-12-11 | — | — | US | disclosed |
| US-20140362545-A1 | ELECTRONIC APPARATUS AND METHOD FOR MANUFACTURING THE SAME | Innolux Corporation (TW) | 2014-12-11 | — | — | US | disclosed |
| US-8114993-B2 | Use of aryl chlorides in palladium-catalyzed C-H bond functionalization | THE UNIVERSITY OF HOUSTON SYSTEM (US) | 2012-02-14 | — | — | US | disclosed |
| US-20090012293-A1 | USE OF ARYL CHLORIDES IN PALLADIUM-CATALYZED C-H BOND FUNCTIONALIZATION | THE UNIVERSITY OF HOUSTON SYSTEM (US) | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012293-A1 | USE OF ARYL CHLORIDES IN PALLADIUM-CATALYZED C-H BOND FUNCTIONALIZATION | DBH, DDT, CYCS | EDNRA 2989/4885ESR1 1645/4885ESR2 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.